The Royal
Melbourne Hospital
Theranostics Schema

The Royal Melbourne Hospital Theranostics SchemaThe Royal Melbourne Hospital Theranostics SchemaThe Royal Melbourne Hospital Theranostics Schema
  • THERANOSTICS
  • RADIOEMBOLISATION
  • RADIOIODINE
  • PSMA
  • More
    • THERANOSTICS
    • RADIOEMBOLISATION
    • RADIOIODINE
    • PSMA

The Royal
Melbourne Hospital
Theranostics Schema

The Royal Melbourne Hospital Theranostics SchemaThe Royal Melbourne Hospital Theranostics SchemaThe Royal Melbourne Hospital Theranostics Schema
  • THERANOSTICS
  • RADIOEMBOLISATION
  • RADIOIODINE
  • PSMA

Yttrium-90 Radioembolisation

Selective Internal Radiation Therapy

SIR-Spheres Resin Microspheres

Personalised predictive dosimetry by Artery-Specific SPECT/CT Partition Model. Worked examples courtesy of Singapore General Hospital.

Download Predictive Calculator & Examples


Video Overview of SIRT Predictive Dosimetry 2022 Theranostics Course, Australia

Concept Overview (SNM 2011 poster), courtesy Singapore General Hospital

Kao et al. Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1084

Kao et al. Scientific basis of personalised tomographic radiation planning for radioembolisation: A form of brachytherapy planning. 

J Med Imaging Radiat Oncol. 2015;59:617-618


Artery-Specific SPECT/CT Partition Model

Kao et al. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization. 

J Nucl Med. 2012;53:559-566


Lung Shunt & Mass by SPECT/CT

Kao et al. Personalized predictive lung dosimetry by technetium-99m macroaggregated albumin SPECT/CT for yttrium-90 radioembolization. 

EJNMMI Res. 2014;4:33


Dose-Response Guidance

Kao YH. Dose-response for yttrium-90 resin microsphere radioembolisation. 

Nucl Med Commun. 2021;42:345-347


Y-90 PET Diagnostic Criteria

Kao et al. Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting. EJNMMI Res. 2013;3:56


Y-90 PET Absorbed Dose Verification

Kao et al. Post-radioembolization yttrium-90 PET/CT - part 2: dose-response and tumor predictive dosimetry for resin microspheres. 

EJNMMI Res. 2013;3:57


Y-90 PET for Residual Activity

Kao et al. 90 Y PET for Qualitative and Quantitative Assessment of Residual Activity in Delivery Apparatus After Radioembolization. 

J Nucl Med Technol. 2021;49:178-179


1. MIRD Method

2. Partition Model

3. Theranostic Surrogate

4. Conceptual problems with BSA Method

5. Soluble Contrast Molecules cannot simulate Particles

6. Interventional Radiology


1. MIRD Method

Toohey et al. The AAPM/RSNA physics tutorial for residents: internal radiation dosimetry: principles and applications. 

Radiographics. 2000;20:533-546


2. Partition Model

Ho et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. 

Eur J Nucl Med. 1996;23:947-952


3. Theranostic Surrogate

Kao YH. A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization. 

J Nucl Med. 2013;54:2191-2192


4. Conceptual Problems with BSA Method

Kao et al. Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review. 

Ann Nucl Med. 2011;25:455-461


Kao YH. Results confounded by a disregard for basic dose-response radiobiology. 

J Nucl Med. 2013;54:1682-1683


Kao YH. Disregard for Basic Dosimetric Principles Will Lead to Questionable Results.

Clin Nucl Med. 2013;38:759


Kao et al. Origin, dosimetric effect and clinical limitations of the semi-empirical body surface area method for radioembolisation using yttrium-90 resin microspheres. 

J Med Imaging Radiat Oncol. 2016;60:382-385


5. Soluble Contrast Molecules cannot simulate Microparticles

Kao et al. Imaging discordance between hepatic angiography versus Tc-99m-MAA SPECT/CT: a case series, technical discussion and clinical implications. 

Ann Nucl Med. 2011;25:669-676


6. Interventional Radiology

Salem et al. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. 

Part 1: Technical and methodologic considerations. 

J Vasc Interv Radiol. 2006;17:1251-1278

Part 2: Special topics. 

J Vasc Interv Radiol. 2006;17:1425-1439

Part 3: Comprehensive literature review and future direction. 

J Vasc Interv Radiol. 2006;17:1571-1593


Radioembolisation to sites other than the Liver

Kao YH. General Theory of Predictive Dosimetry for Yttrium-90 Radioembolization to Sites Other than the Liver. 

Cardiovasc Intervent Radiol. 2014;37:1114-1117


Tumour-to-Lung Shunt: conventional Liver-to-Lung Shunt formularism is only partially correct, sometimes completely wrong

Kao YH. Dosimetric theory for tumor-to-lung shunt fraction calculation in yttrium-90 radioembolization of noncirrhotic livers. 

Nucl Med Commun. 2014;35:331-332 


The Holy Gray

Kao YH. Yes, the Holy Gray exists. Learn from modern radioembolisation. 

Eur J Nucl Med Mol Imaging. 2021;48:4115-4117


Rapid Predictive Dosimetry

Kao YH. Rapid predictive dosimetry for radioembolization. 

Asia Ocean J Nucl Med Biol. 2024;12:35-36



Downloads

Kao Predictive Calculator SIRT (xlsx)Download
Kao Rapid Predictive Calculator SIRT (xlsx)Download
Kao SNM 2011 Poster (pdf)Download
Kao 2011 Example Single Artery (pdf)Download
Kao 2011 Example Three Arteries (pdf)Download
Kao 2011 Example Sublesional (pdf)Download
Kao Lung SPECTCT Diaphragm (pdf)Download

Powered by